Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparative Effects of Moxonidine and Bisoprolol on Bone Metabolism, Vascular and Cellular Markers of Aging, Blood Pressure in Hypertensive Postmenopausal Women (COMPASS)

Next Previous
Trial Profile

Comparative Effects of Moxonidine and Bisoprolol on Bone Metabolism, Vascular and Cellular Markers of Aging, Blood Pressure in Hypertensive Postmenopausal Women (COMPASS)

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 06 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Moxonidine (Primary) ; Bisoprolol
  • Indications Hypertension; Metabolic bone diseases
  • Focus Biomarker; Pharmacodynamics
  • Acronyms COMPASS

Most Recent Events

  • 14 Apr 2021 Results assessing the effect of moxonidine versus bisoprolol on cellular senescence processes in postmenopausal women with arterial hypertension, presented at the Joint Meeting of the European Society of Hypertension and International Society of Hypertension.
  • 27 Jul 2018 Status changed from active, no longer recruiting to completed.
  • 28 Mar 2018 Planned End Date changed from 1 Dec 2017 to 1 May 2018.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top